Clinical trial · Observational
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
NCT07303725CI-TRIAL-00099712recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer (Primary and Metastatic) | Malignant Liver Neoplasm | CURATED_EXACT | 0.85 |
| Renal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- angiography mapping
- description
- Hepatocellular carcinoma (HCC) patients undergoing hepatic angiography mapping prior to TARE (N=10)
- label
- microwave ablation
- description
- percutaneous tumor ablation in patients receiving image-guided tumor ablation using MWA (n=10)
- label
- cryoablation
- description
- cryoablation (N=10) for primary liver (HCC) or primary kidney tumors (RCC)
Primary outcomes (1)
- measure
- CT image
- timeFrame
- Baseline
- description
- Effective Dose and CTDI
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: 1. Age \> or = 18 years 2. Tumor in an area without prior surgical or ablative therapy 3. At least 1 tumor greater than 1.5 cm in greatest diameter Exclusion criteria: 1. Not eligible for indicated procedure. 2. BMI \> 35 3. Prior surgery.
References
Publications (0)
Data not yet available
No reference posted for this study.